Revvity (NYSE:RVTY) Reaches New 52-Week High – Here’s Why

Revvity Inc. (NYSE:RVTY) hit a new 52-week high on Wednesday . The stock traded as high as $131.09 and last traded at $129.91, with a volume of 100609 shares changing hands. The stock had previously closed at $126.59.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on RVTY shares. TD Cowen reaffirmed a “buy” rating on shares of Revvity in a research note on Wednesday, July 15th. Sanford C. Bernstein began coverage on shares of Revvity in a report on Friday, June 26th. They set a “market perform” rating and a $115.00 price objective for the company. Royal Bank Of Canada initiated coverage on shares of Revvity in a report on Tuesday. They issued a “sector perform” rating and a $135.00 target price on the stock. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Finally, Wolfe Research started coverage on Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Three analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $110.58.

Revvity Stock Down 0.1%

The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The stock has a market capitalization of $14.59 billion, a price-to-earnings ratio of 62.27, a P/E/G ratio of 2.38 and a beta of 1.09. The firm’s fifty day simple moving average is $116.07 and its 200 day simple moving average is $102.05.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. During the same quarter in the prior year, the company earned $1.18 earnings per share. The business’s quarterly revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, sell-side analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s dividend payout ratio is presently 13.33%.

Hedge Funds Weigh In On Revvity

A number of large investors have recently added to or reduced their stakes in RVTY. California State Teachers Retirement System lifted its holdings in shares of Revvity by 10,607.8% in the second quarter. California State Teachers Retirement System now owns 14,328,063 shares of the company’s stock valued at $1,594,140,000 after purchasing an additional 14,194,254 shares in the last quarter. EdgePoint Investment Group Inc. grew its holdings in shares of Revvity by 3.1% during the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock worth $771,044,000 after buying an additional 265,204 shares in the last quarter. Jupiter Topco LLC acquired a new stake in Revvity in the 2nd quarter valued at approximately $961,017,000. Price T Rowe Associates Inc. MD raised its position in Revvity by 5.3% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock valued at $832,693,000 after buying an additional 434,570 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its stake in Revvity by 2.3% in the 1st quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company’s stock valued at $731,386,000 after acquiring an additional 186,956 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.